#BEGIN_DRUGCARD DB02267

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C10H18N4O6

# Chemical_IUPAC_Name:
(2R)-2-{3-[(4S)-4-amino-4-carboxybutyl]carbamimidamido}butanedioic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Argininosuccinate

# HET_ID:
AS1

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C10H18N4O6/c11-5(8(17)18)2-1-3-13-10(12)14-6(9(19)20)4-7(15)16/h5-6H,1-4,11H2,(H,15,16)(H,17,18)(H,19,20)(H3,12,13,14)/t5-,6+/m0/s1

# InChI_Key:
InChIKey=KDZOASGQNOPSCU-NTSWFWBYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2267

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
290.2731

# Molecular_Weight_Mono:
290.122634328

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1TJW

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-3.2

# Predicted_LogS:
-2.8

# Predicted_Water_Solubility:
4.56e-01 g/l

# Primary_Accession_No:
DB02267

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
448718

# PubChem_Substance_ID:
46504554

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00565

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
N[C@@H](CCCNC(=N)N[C@H](CC(O)=O)C(O)=O)C(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:57 -0700

# Wikipedia_Link:
http://en.wikipedia.org/wiki/Argininosuccinate

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
ASL

# Drug_Target_1_GenBank_ID_Gene:
Y00753

# Drug_Target_1_GenBank_ID_Protein:
28878

# Drug_Target_1_GeneCard_ID:
ASL

# Drug_Target_1_Gene_Name:
ASL

# Drug_Target_1_Gene_Sequence:
>1395 bp
ATGGCCTCGGAGAGTGGGAAGCTTTGGGGTGGCCGGTTTGTGGGTGCAGTGGACCCCATC
ATGGAGAAGTTCAACGCGTCCATTGCCTACGACCGGCACCTTTGGGAGGTGGATGTTCAA
GGCAGCAAAGCCTACAGCAGGGGCCTGGAGAAGGCAGGGCTCCTCACCAAGGCCGAGATG
GACCAGATACTCCATGGCCTAGACAAGGTGGCTGAGGAGTGGGCCCAGGGCACCTTCAAA
CTGAACTCCAATGATGAGGACATCCACACAGCCAATGAGCGCCGCCTGAAGGAGCTCATT
GGTGCAACGGCAGGGAAGCTGCACACGGGACGGAGCCGGAATGACCAGGTGGTCACAGAC
CTCAGGCTGTGGATGCGGCAGACCTGCTCCACGCTCTCGGGCCTCCTCTGGGAGCTCATT
AGGACCATGGTGGATCGGGCAGAGGCGGAACGTGATGTTCTCTTCCCGGGGTACACCCAT
TTGCAGAGGGCCCAGCCCATCCGCTGGAGCCACTGGATTCTGAGCCACGCCGTGGCACTG
ACCCGAGACTCTGAGCGGCTGCTGGAGGTGCGGAAGCGGATCAATGTCCTGCCCCTGGGG
AGTGGGGCCATTGCAGGCAATCCCCTGGGTGTGGACCGAGAGCTGCTCCGAGCAGAACTC
AACTTTGGGGCCATCACTCTCAACAGCATGGATGCCACTAGTGAGCGGGACTTTGTGGCC
GAGTTCCTGTTCTGGCGTTCGCTGTGCATGACCCATCTCAGCAGGATGGCCGAGGACCTC
ATCCTCTACTGCACCAAGGAATTCAGCTTCGTGCAGCTCTCAGATGCCTACAGCACGGGA
AGCAGCCTGATGCCCCAGAAGAAAAACCCCGACAGTTTGGAGCTGATCCGGAGCAAGGCT
GGGCGTGTGTTTGGGCGGTGTGCCGGGCTCCTGATGACCCTCAAGGGACTTCCCAGCACC
TACAACAAAGACTTACAGGAGGACAAGGAAGCTGTGTTTGAAGTGTCAGACACTATGAGT
GCCGTGCTCCAGGTGGCCACTGGCGTCATCTCTACGCTGCAGATTCACCAAGAGAACATG
GGACAGGCTCTCAGCCCCGACATGCTGGCCACTGACCTTGCCTATTACCTGGTCCGCAAA
GGGATGCCATTCCGCCAGGCCCATGAGGCCTCCGGGAAAGCTGTGTTCATGGCCGAGACC
AAGGGGGTCGCCCTCAACCAGCTGTCACTGCAGGAGCTGCAGACCATCAGCCCCCTGTTC
TCGGGCGACGTGATCTGCGTGTGGGACTACCGGCACAGTGTGGAGCAGTATGGTGCCCTG
GGCGGCACTGCGCGCTCCAGCGTCGACTGGCAAATCCGCCAGGTGCGGGCGCTACTGCAG
GCACAGCAGGCCTAG

# Drug_Target_1_General_Function:
Amino acid transport and metabolism

# Drug_Target_1_General_References:
11747432	Sampaleanu LM, Vallee F, Thompson GD, Howell PL: Three-dimensional structure of the argininosuccinate lyase frequently complementing allele Q286R. Biochemistry. 2001 Dec 25;40(51):15570-80.
12408190	Kleijer WJ, Garritsen VH, Linnebank M, Mooyer P, Huijmans JG, Mustonen A, Simola KO, Arslan-Kirchner M, Battini R, Briones P, Cardo E, Mandel H, Tschiedel E, Wanders RJ, Koch HG: Clinical, enzymatic, and molecular genetic characterization of a biochemical variant type of argininosuccinic aciduria: prenatal and postnatal diagnosis in five unrelated families. J Inherit Metab Dis. 2002 Sep;25(5):399-410.
1705937	Barbosa P, Cialkowski M, O'Brien WE: Analysis of naturally occurring and site-directed mutations in the argininosuccinate lyase gene. J Biol Chem. 1991 Mar 15;266(8):5286-90.
2263616	Walker DC, McCloskey DA, Simard LR, McInnes RR: Molecular analysis of human argininosuccinate lyase: mutant characterization and alternative splicing of the coding region. Proc Natl Acad Sci U S A. 1990 Dec;87(24):9625-9.
2644168	Todd S, McGill JR, McCombs JL, Moore CM, Weider I, Naylor SL: cDNA sequence, interspecies comparison, and gene mapping analysis of argininosuccinate lyase. Genomics. 1989 Jan;4(1):53-9.
3391281	Matuo S, Tatsuno M, Kobayashi K, Saheki T, Miyata T, Iwanaga S, Amaya Y, Mori M: Isolation of cDNA clones of human argininosuccinate lyase and corrected amino acid sequence. FEBS Lett. 1988 Jul 18;234(2):395-9.
3463959	O'Brien WE, McInnes R, Kalumuck K, Adcock M: Cloning and sequence analysis of cDNA for human argininosuccinate lyase. Proc Natl Acad Sci U S A. 1986 Oct;83(19):7211-5.
9256435	Turner MA, Simpson A, McInnes RR, Howell PL: Human argininosuccinate lyase: a structural basis for intragenic complementation. Proc Natl Acad Sci U S A. 1997 Aug 19;94(17):9063-8.

# Drug_Target_1_HGNC_ID:
HGNC:746

# Drug_Target_1_HPRD_ID:
01948

# Drug_Target_1_ID:
577

# Drug_Target_1_Locus:
7cen-q11.2

# Drug_Target_1_Molecular_Weight:
51744

# Drug_Target_1_Name:
Argininosuccinate lyase

# Drug_Target_1_Number_of_Residues:
464

# Drug_Target_1_PDB_ID:
1K62

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00206	Lyase_1

# Drug_Target_1_Protein_Sequence:
>Argininosuccinate lyase
MASESGKLWGGRFVGAVDPIMEKFNASIAYDRHLWEVDVQGSKAYSRGLEKAGLLTKAEM
DQILHGLDKVAEEWAQGTFKLNSNDEDIHTANERRLKELIGATAGKLHTGRSRNDQVVTD
LRLWMRQTCSTLSGLLWELIRTMVDRAEAERDVLFPGYTHLQRAQPIRWSHWILSHAVAL
TRDSERLLEVRKRINVLPLGSGAIAGNPLGVDRELLRAELNFGAITLNSMDATSERDFVA
EFLFWRSLCMTHLSRMAEDLILYCTKEFSFVQLSDAYSTGSSLMPQKKNPDSLELIRSKA
GRVFGRCAGLLMTLKGLPSTYNKDLQEDKEAVFEVSDTMSAVLQVATGVISTLQIHQENM
GQALSPDMLATDLAYYLVRKGMPFRQAHEASGKAVFMAETKGVALNQLSLQELQTISPLF
SGDVICVWDYGHSVEQYGALGGTARSSVDWQIRQVRALLQAQQA

# Drug_Target_1_Reaction:
2-(Nomega-L-arginino)succinate = fumarate + L-arginine

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Not Available

# Drug_Target_1_SwissProt_ID:
P04424

# Drug_Target_1_SwissProt_Name:
ARLY_HUMAN

# Drug_Target_1_Synonyms:
ASAL
Arginosuccinase
EC 4.3.2.1

# Drug_Target_1_Theoretical_pI:
6.59

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Cytoplasm (Probable)

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
AP008226

# Drug_Target_2_GenBank_ID_Protein:
55771665

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
argG

# Drug_Target_2_Gene_Sequence:
>1203 bp
CTATGCGCCATGGCCCTCCCTCTCCACAAGGGCCCGCACCCGGAGGCGCAGGGCCTGGAT
CTTGATGAAGCCCTCGGCGTCCTTCTGGTCGTAGCCCCCTGCCTCGTCAAAGGAGACCAG
GTCCTGGCGGTAGAGGCTCTTCGGGGCCTTCCTTCCCACCACGTAGACGTTCCCCTTGTA
GAGCTTGAGCCGGGCCACGCCGGTGACGCTTCTCGCCACGTGGTCAAAGTAGGCCTGAAG
GGCCTCCCGCTCCGGGGCGTACCAGAAGCCGTAGTAGACGAGCTCGGCGTACTTGGGGGA
GAGCATGTCCCTTTGGTGGAGGACCTCCCGGTCCAGGGTGAGGCTTTCCACCGCCCGCCT
GGCGTGGTAGAGGATCGTCCCCCCCGGGGTCTCGTAGACCCCCCGGGACTTCATGCCCAC
AAAGCGGTTCTCCACGATGTCCACCCGGCCCACCCCGTGACGCCCCCCGATCTCGTTGAG
CCTCTGCAGAAGGGCCGCCGGGGAAAGCCTCTCCCCGTTCACCGCCACGGGATCGCCCTC
AAAAAACTCCACCTCCACGTACTCCGGGGCGTCGGGAGCCTCCTCGGGGTCTTGGGTCAT
GCGGAACATCCCCTTGGGGGGCTCGGCCCAGGGGTCCTCGAGGACCCCGCCCTCGTAGGA
AATATGCAAGAGGTTGGCGTCCATGGAGTAAGGCTTCTCCTGGGTCACGGGGACGGGAAT
GCCGTGGGCCTCGGCGTAGGCGATCATCTCCTTGCGGCCCTGGAAGCTCCACTCCCGCCA
GGGGGCGATGACCTTGATGTCGGGCTTCAGGGCGTAGGCGGTGAGCTCAAAGCGCACCTG
GTCGTTCCCCTTCCCCGTGGCCCCGTGGGCGATGGCCTCCGCCCCCTCCTCCTCGGCGAT
CCGCACCAGGTGCTTGGCGATCAAAGGCCTCGCGATGGAAGTGCCGAGGAGGTAGTAGCC
CTCGTACACCGCGCCAGCCCGCATCATGGGGAAGACGAAGTCGCGGACGAACTCCTCCTT
GAGGTCCAGGGCGATGGCCTTGGAAGCGCCCGTCCTCAGCGCCTTCTCCCGGGCCTCCTC
CACCTCCTCCCCCTGGCCGATGTCCGCGGTGAAGGCGATGACCTCGGCCCGATAGGTCTC
CTTGAGCCACTTGAGGATGATGCTGGTGTCCAGTCCGCCGGAGTAGGCCAAGACGATCTT
CAT

# Drug_Target_2_General_Function:
Amino acid transport and metabolism

# Drug_Target_2_General_References:
11844799	Goto M, Nakajima Y, Hirotsu K: Crystal structure of argininosuccinate synthetase from Thermus thermophilus HB8. Structural basis for the catalytic action. J Biol Chem. 2002 May 3;277(18):15890-6. Epub 2002 Feb 13.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
2680

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
44817

# Drug_Target_2_Name:
Argininosuccinate synthase

# Drug_Target_2_Number_of_Residues:
400

# Drug_Target_2_PDB_ID:
1KH3

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00764	Arginosuc_synth

# Drug_Target_2_Protein_Sequence:
>Argininosuccinate synthase
MKIVLAYSGGLDTSIILKWLKETYRAEVIAFTADIGQGEEVEEAREKALRTGASKAIALD
LKEEFVRDFVFPMMRAGAVYEGYYLLGTSIARPLIAKHLVRIAEEEGAEAIAHGATGKGN
DQVRFELTAYALKPDIKVIAPWREWSFQGRKEMIAYAEAHGIPVPVTQEKPYSMDANLLH
ISYEGGVLEDPWAEPPKGMFRMTQDPEEAPDAPEYVEVEFFEGDPVAVNGERLSPAALLQ
RLNEIGGRHGVGRVDIVENRFVGMKSRGVYETPGGTILYHARRAVESLTLDREVLHQRDM
LSPKYAELVYYGFWYAPEREALQAYFDHVARSVTGVARLKLYKGNVYVVGRKAPKSLYRQ
DLVSFDEAGGYDQKDAEGFIKIQALRLRVRALVEREGHGA

# Drug_Target_2_Reaction:
ATP + L-citrulline + L-aspartate = AMP + diphosphate + 2-(Nomega-L-arginino)succinate

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
ATP + L-citrulline + L-aspartate = AMP + diphosphate + omega-N-(L-arginino)succinate

# Drug_Target_2_SwissProt_ID:
P59846

# Drug_Target_2_SwissProt_Name:
ASSY_THET8

# Drug_Target_2_Synonyms:
Citrulline--aspartate ligase
EC 6.3.4.5

# Drug_Target_2_Theoretical_pI:
5.71

# Drug_Target_2_Transmembrane_Regions:
None

#END_DRUGCARD DB02267
